| 11월 07일 |
12:00-13:00 |
Registration |
|
| 13:00-13:10 |
Opening Remarks |
| 13:10-13:20 |
축사 |
| Session 1: Fibrosis in liver |
| 13:20-13:50 |
Unveiling the Role of Iron Homeostasis in Liver Fibrosis and Metabolic Diseases |
한창엽(전북대학교) |
권택규(계명대학교), 배광희(KRIBB) |
| 13:50-14:20 |
Cross-talk between Hepatic Stellate Cells and Diverse Immune Cells in Liver Fibrosis |
정원일(KAIST) |
| 14:20-14:50 |
Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis |
이유미(경북대) |
| 14:50-15:00 |
Coffee Break |
| Session 2: Fibrosis in lung |
| 15:00-15:30 |
Macrophage as a Driver of Fibrosis in Asthma: Implications for Airway Remodeling |
강혜련(서울대학교병원) |
이한웅(연세대학교),
전경희(연세대학교)
|
| 15:30-16:00 |
Tissue-specific dual functions of WNT/RYK signaling in lung development and diseases |
김현택(순천향의생명연구원) |
| 16:00-16:30 |
Role of Alveolar Stem Cells in the Pathogenesis of Pulmonary Emphysema and Lung Carcinogenesis |
부혜진(제주대학교) |
| 16:30-16:40 |
Coffee Break |
| Plenary Lecture |
| 16:40-17:00 |
Cereblon, molecular chaperones and cellular proteostasis: therapeutic potentials for neurodegenerative diseases |
박철승(GIST) |
양영(숙명여자대학교) |
| 17:00-17:20 |
KLC3 regulates ciliary trafficking in CILK1 deficient ADPKD |
박종훈(숙명여자대학교) |
| Special Session (JBS) |
| 17:20-17:50 |
Pathogenic role of the pro-fibrotic BATokine in cardiovascular-metabolic diseases |
Ippei Shimizu
(National Cerebral and Cardiovascular Center) |
권호정(연세대학교)
|
| 국가신약개발재단 소개 |
| 17:50-18:05 |
Introduction of Korea Drug Development Fund |
박영민(국가신약개발재단) |
장우철(부산대학교) |
| 18:05-18:10 |
Group Photo |
| 18:10 |
보문학술대회 총회 &석식 |
| 11월 08일 |
Session 3 : Fibrosis in others |
| 10:00-10:30 |
Kidney-resident macrophages in inflammation-induced fibrosis |
한승석(서울대학교) |
조사연(중앙대학교), 정영미(부산대학교) |
| 10:30-11:00 |
The therapeutic potential of targeting m6A RNA methylation in kidney fibrosis |
조성엽(서울대학교) |
| 11:00-11:30 |
Targeting Fibrosis with a Dual FXR and PPARα Agonist |
정기웅(부산대학교) |
| 11:30-12:20 |
Lunch |
| 12:20-12:30 |
Closing remark |
